drugset / Trial / NCT00685022
Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to compare the safety and tolerability of levalbuterol HFA metered dose inhaler (MDI) versus racemic albuterol HFA MDI.
Timeline
- Start
- 2003-06
- Primary completion
- 2003-08
- Completion
- 2003-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levalbuterol | Other / unclassified | 45 ug | — |
| Comparator | racemic albuterol | Unknown | 90 ug | — |